Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NK

NantKwest (NK) Stock Price, News & Analysis

NantKwest logo

About NantKwest Stock (NASDAQ:NK)

Advanced Chart

Key Stats

Today's Range
$2.29
$2.40
50-Day Range
$16.09
$38.70
52-Week Range
$2.52
$45.42
Volume
5.64 million shs
Average Volume
1.57 million shs
Market Capitalization
$255.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NantKwest and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NK Stock News Headlines

INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.tc pixel
Space Nk Promo Codes
See More Headlines

NK Stock Analysis - Frequently Asked Questions

NantKwest, Inc. (NASDAQ:NK) released its quarterly earnings data on Monday, May, 11th. The biotechnology company reported ($0.19) EPS for the quarter, missing analysts' consensus estimates of ($0.17) by $0.02. The biotechnology company earned $0.02 million during the quarter. NantKwest had a negative trailing twelve-month return on equity of 56.06% and a negative net margin of 76,658.58%.

NantKwest (NK) raised $150 million in an initial public offering (IPO) on Tuesday, July 28th 2015. The company issued 7,000,000 shares at $20.00-$23.00 per share. BofA Merrill Lynch, Citigroup, Jefferies and Piper Jaffray acted as the underwriters for the IPO and MLV & Co. was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that NantKwest investors own include Sorrento Therapeutics (SRNE), Gilead Sciences (GILD), NVIDIA (NVDA), Advanced Micro Devices (AMD), Pfizer (PFE), Dynavax Technologies (DVAX) and OPKO Health (OPK).

Company Calendar

Last Earnings
5/11/2020
Today
8/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:NK
CIK
1326110
Fax
N/A
Employees
160
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.70)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$65.79 million
Net Margins
-76,658.58%
Pretax Margin
N/A
Return on Equity
-56.06%
Return on Assets
-46.93%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.74
Quick Ratio
4.74

Sales & Book Value

Annual Sales
$40 thousand
Price / Sales
6,396.68
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.23 per share
Price / Book
1.90

Miscellaneous

Outstanding Shares
109,345,000
Free Float
N/A
Market Cap
$255.87 million
Optionable
Not Optionable
Beta
2.61
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:NK) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners